Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Intestinal2466 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A18078 | 27363235 | Adolesc Med State Art Rev | Gastrointestinal Conditions in the Obese Patient. | 2016 | Details |
| A18087 | 29544827 | Food Res Int | Dietary whey proteins shield murine cecal microbiota from extensive disarray caused by a high-fat diet. | 2016 | Details |
| A18103 | 27350543 | Pediatr Obes | Multiple gut-liver axis abnormalities in children with obesity with and without hepatic involvement. | 2016 | Details |
| A18111 | 27347379 | F1000Res | A computer model simulating human glucose absorption and metabolism in health and metabolic disease states. | 2016 | Details |
| A18120 | 27342212 | Gastroenterology | Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol. | 2016 | Details |
| A18139 | 27324067 | Metabolism | Nonalcoholic fatty liver disease and obstructive sleep apnea. | 2016 | Details |
| A18148 | 27321390 | Pathol Int | Novel function of histamine signaling via histamine receptors in cholesterol and bile acid metabolism: Histamine H2 receptor protects against nonalcoholic fatty liver disease. | 2016 | Details |
| A18178 | 27308646 | J Gastrointestin Liver Dis | Small Intestinal Bacterial Overgrowth Is Associated with Non-Alcoholic Fatty Liver Disease. | 2016 | Details |
| A18185 | 27304953 | Int J Mol Sci | Effects of Probiotics and Synbiotics on Obesity, Insulin Resistance Syndrome, Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease: A Review of Human Clinical Trials. | 2016 | Details |
| A18191 | 27298379 | Gut | Carvedilol delays the progression of small oesophageal varices in patients with cirrhosis: a randomised placebo-controlled trial. | 2016 | Details |
| A18196 | 27291420 | Sci Rep | Hyperlipidemia and hepatitis in liver-specific CREB3L3 knockout mice generated using a one-step CRISPR/Cas9 system. | 2016 | Details |
| A18202 | 27288420 | Am J Physiol Gastrointest Liver Physiol | Gut microbiota are linked to increased susceptibility to hepatic steatosis in low-aerobic-capacity rats fed an acute high-fat diet. | 2016 | Details |
| A18205 | 27287838 | Orv Hetil | [Non-alcoholic fatty liver disease and hepatocellular carcinoma - 2016]. | 2016 | Details |
| A18226 | 27273788 | Int J Cancer | Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis. | 2016 | Details |
| A18227 | 27273168 | Nat Rev Gastroenterol Hepatol | The role of the gut microbiota in NAFLD. | 2016 | Details |
| A18256 | 27261901 | Gastroenterol Clin North Am | Obesity in Women: The Clinical Impact on Gastrointestinal and Reproductive Health and Disease Management. | 2016 | Details |
| A18274 | 27248703 | J Gastroenterol Hepatol | "We are what our bacteria eat": The role of bacteria in personalizing nutrition therapy in gastrointestinal conditions. | 2017 | Details |
| A18278 | 27247565 | Gastroenterol Res Pract | The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic Background. | 2016 | Details |
| A18313 | 27219496 | Endocr Pract | AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY. | 2016 | Details |
| A18331 | 27203081 | PLoS One | Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease. | 2016 | Details |
| A18336 | 27197843 | Br J Nutr | Preventive effects of citrulline on Western diet-induced non-alcoholic fatty liver disease in rats. | 2016 | Details |
| A18341 | 27196572 | Gut | Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism. | 2016 | Details |
| A18345 | 27190693 | World J Gastrointest Pathophysiol | Insulin resistance in development and progression of nonalcoholic fatty liver disease. | 2016 | Details |
| A18350 | 27187452 | Nutrients | Gut Microbiota and Metabolic Health: The Potential Beneficial Effects of a Medium Chain Triglyceride Diet in Obese Individuals. | 2016 | Details |
| A18351 | 27187365 | Int J Mol Sci | Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers. | 2016 | Details |
| A18432 | 27142672 | Dig Dis Sci | Impact of Hypocaloric Hyperproteic Diet on Gut Microbiota in Overweight or Obese Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study. | 2016 | Details |
| A18453 | 27124954 | Genome Med | Antibiotic perturbation of the murine gut microbiome enhances the adiposity, insulin resistance, and liver disease associated with high-fat diet. | 2016 | Details |
| A18463 | 27111464 | J Appl Microbiol | Gut microbiota-associated bile acid deconjugation accelerates hepatic steatosis in ob/ob mice. | 2016 | Details |
| A18473 | 27105827 | Nutr J | Pathophysiological role of host microbiota in the development of obesity. | 2016 | Details |
| A18503 | 27086596 | J Pathol Transl Med | Interobserver Agreement on Pathologic Features of Liver Biopsy Tissue in Patients with Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18509 | 27085070 | Biochim Biophys Acta | Unique microbial-derived volatile organic compounds in portal venous circulation in murine non-alcoholic fatty liver disease. | 2016 | Details |
| A18545 | 27063268 | Clin Liver Dis | Nonalcoholic Fatty Liver Disease and the Gut Microbiome. | 2015 | Details |
| A18581 | 27048904 | Best Pract Res Clin Gastroenterol | Intestinal microbiota in liver disease. | 2016 | Details |
| A18611 | 27036035 | Oncotarget | Distinctly altered gut microbiota in the progression of liver disease. | 2016 | Details |
| A18612 | 27035833 | PLoS One | Overexpression of Peroxiredoxin 4 Affects Intestinal Function in a Dietary Mouse Model of Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18614 | 27032902 | J Appl Physiol (1985) | Short-term aerobic exercise training improves gut peptide regulation in nonalcoholic fatty liver disease. | 2016 | Details |
| A18624 | 27028797 | Hepatology | Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach. | 2016 | Details |
| A18632 | 27023533 | Int J Mol Sci | Gut Microbiota and Lifestyle Interventions in NAFLD. | 2016 | Details |
| A18642 | 27018382 | Biochem Biophys Res Commun | Protective effects of Lactobacillus rhamnosus GG against dyslipidemia in high-fat diet-induced obese mice. | 2016 | Details |
| A18654 | 27012627 | J Nutr Biochem | Hydroxytyrosol prevents metabolic impairment reducing hepatic inflammation and restoring duodenal integrity in a rat model of NAFLD. | 2016 | Details |
| A18659 | 27010240 | J Gastroenterol Hepatol | Asian consensus on the relationship between obesity and gastrointestinal and liver diseases. | 2016 | Details |
| A18683 | 26999104 | Int J Mol Sci | Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of Metabolomics. | 2016 | Details |
| A18762 | 26962021 | Biochim Biophys Acta | Nuclear receptors and nonalcoholic fatty liver disease. | 2016 | Details |
| A18777 | 26948887 | Gastroenterology | Changes in the Intestinal Microbiome and Alcoholic and Nonalcoholic Liver Diseases: Causes or Effects? | 2016 | Details |
| A18817 | 26923892 | Arch Iran Med | Modulation of Gut Microbiota by Berberine Improves Steatohepatitis in High-Fat Diet-Fed BALB/C Mice. | 2016 | Details |
| A18842 | 26907882 | Nat Rev Gastroenterol Hepatol | Management of NAFLD: a stage-based approach. | 2016 | Details |
| A18857 | 26898658 | Dig Dis Sci | Gut Microbiota of Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18865 | 26894897 | Cell Mol Life Sci | Pathogenesis of nonalcoholic steatohepatitis. | 2016 | Details |
| A18879 | 26890069 | Mol Nutr Food Res | Fuzhuan tea consumption imparts hepatoprotective effects and alters intestinal microbiota in high saturated fat diet-fed rats. | 2016 | Details |
| A18886 | 26886386 | Eur J Gastroenterol Hepatol | Characteristics and outcomes of transjugular intrahepatic portosystemic shunt recipients in the VA Healthcare System. | 2016 | Details |
| A18909 | 26874076 | Gastroenterology | Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening. | 2016 | Details |
| A18939 | 26858714 | Front Microbiol | Ethanol Production by Selected Intestinal Microorganisms and Lactic Acid Bacteria Growing under Different Nutritional Conditions. | 2016 | Details |
| A19006 | 26823198 | Metabolism | The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). | 2016 | Details |
| A19014 | 26818807 | Sci Rep | Involvement of resistin-like molecule β in the development of methionine-choline deficient diet-induced non-alcoholic steatohepatitis in mice. | 2016 | Details |
| A19089 | 26773011 | Adv Nutr | Choline, Its Potential Role in Nonalcoholic Fatty Liver Disease, and the Case for Human and Bacterial Genes. | 2016 | Details |
| A19120 | 26748629 | J Hepatobiliary Pancreat Sci | Do pancrelipase delayed-release capsules have a protective role against nonalcoholic fatty liver disease after pancreatoduodenectomy in patients with pancreatic cancer? A randomized controlled trial. | 2016 | Details |
| A19125 | 26743949 | Sci Rep | Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults. | 2016 | Details |
| A19143 | 26730275 | World J Hepatol | Management of non-alcoholic fatty liver disease in 2015. | 2015 | Details |
| A19197 | 26711682 | Dig Liver Dis | Celiac disease-related hepatic injury: Insights into associated conditions and underlying pathomechanisms. | 2015 | Details |
| A19210 | 26702135 | Am J Physiol Gastrointest Liver Physiol | Deficiency of intestinal mucin-2 protects mice from diet-induced fatty liver disease and obesity. | 2015 | Details |
| A19211 | 26699443 | J Gastroenterol Hepatol | Red pitaya betacyanins protects from diet-induced obesity, liver steatosis and insulin resistance in association with modulation of gut microbiota in mice. | 2016 | Details |
| A19233 | 26682925 | Biochem Biophys Res Commun | DSS colitis promotes tumorigenesis and fibrogenesis in a choline-deficient high-fat diet-induced NASH mouse model. | 2015 | Details |
| A19275 | 26663004 | Hepatobiliary Pancreat Dis Int | Gut microbiota and non-alcoholic fatty liver disease. | 2015 | Details |
| A19279 | 26657927 | Minerva Gastroenterol Dietol | Probiotics in digestive diseases: focus on Lactobacillus GG. | 2015 | Details |
| A19280 | 26657326 | Gastroenterology | Circadian Clock Control of Liver Metabolic Functions. | 2015 | Details |
| A19281 | 26656334 | Medicine (Baltimore) | Nonalcoholic Cirrhosis Increased Risk of Digestive Tract Malignancies: A Population-Based Cohort Study. | 2015 | Details |
| A19310 | 26635079 | BMC Gastroenterol | Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol. | 2015 | Details |
| A19360 | 26608256 | Lancet | Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. | 2015 | Details |
| A19372 | 26600967 | World J Gastrointest Pathophysiol | Starring role of toll-like receptor-4 activation in the gut-liver axis. | 2015 | Details |
| A19376 | 26600078 | Hepatology | The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. | 2016 | Details |
| A19387 | 26594831 | J Pediatr Gastroenterol Nutr | Liver Disease in Pediatric Patients With Ataxia Telangiectasia: A Novel Report. | 2016 | Details |
| A19460 | 26556989 | World J Gastroenterol | Gut microbiota and host metabolism in liver cirrhosis. | 2015 | Details |
| A19490 | 26524607 | Scand J Immunol | Effect of Lipopolysaccharide on the Progression of Non-Alcoholic Fatty Liver Disease in High Caloric Diet-Fed Mice. | 2016 | Details |
| A19493 | 26524133 | Expert Rev Gastroenterol Hepatol | The role of chronic inflammation in the development of gastrointestinal cancers: reviewing cancer prevention with natural anti-inflammatory intervention. | 2015 | Details |
| A19577 | 26474417 | PLoS One | Naturally Occurring Stilbenoid TSG Reverses Non-Alcoholic Fatty Liver Diseases via Gut-Liver Axis. | 2015 | Details |
| A19583 | 26473416 | Annu Rev Med | Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis. | 2015 | Details |
| A19593 | 26465278 | Vnitr Lek | [The role of metabolic syndrome in gastroenterology]. | 2015 | Details |
| A19622 | 26450277 | Br J Nutr | Supplementation of sodium butyrate protects mice from the development of non-alcoholic steatohepatitis (NASH). | 2015 | Details |
| A19623 | 26449892 | Nutr Clin Pract | Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19629 | 26447961 | J Clin Gastroenterol | Probiotics in Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Cirrhosis. | 2016 | Details |
| A19633 | 26447006 | JBI Database System Rev Implement Rep | Impact of physical and psychological factors on health-related quality of life in adult patients with liver cirrhosis: a systematic review protocol. | 2015 | Details |
| A19658 | 26432021 | Trends Mol Med | Emerging Liver-Kidney Interactions in Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19660 | 26430826 | J Am Coll Nutr | Effects of Multistrain Probiotic Supplementation on Glycemic and Inflammatory Indices in Patients with Nonalcoholic Fatty Liver Disease: A Double-Blind Randomized Clinical Trial. | 2015 | Details |
| A19700 | 26405687 | Cell Mol Gastroenterol Hepatol | Hepatic Injury in Nonalcoholic Steatohepatitis Contributes to Altered Intestinal Permeability. | 2015 | Details |
| A19718 | 26396715 | Middle East J Dig Dis | Trend of Gastrointestinal and Liver Diseases in Iran: Results of the Global Burden of Disease Study, 2010. | 2015 | Details |
| A19745 | 26378648 | Semin Liver Dis | Pharmacotherapy for Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19750 | 26378643 | Semin Liver Dis | The Gut Microbiota and Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19757 | 26377647 | Toxicol Sci | 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Alters Lipid Metabolism and Depletes Immune Cell Populations in the Jejunum of C57BL/6 Mice. | 2015 | Details |
| A19758 | 26375281 | PLoS One | Co-Administration of Cholesterol-Lowering Probiotics and Anthraquinone from Cassia obtusifolia L. Ameliorate Non-Alcoholic Fatty Liver. | 2015 | Details |
| A19779 | 26355465 | Inflamm Bowel Dis | PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes. | 2016 | Details |
| A19808 | 26338727 | Gut | The gut microbiota and host health: a new clinical frontier. | 2015 | Details |
| A19831 | 26318867 | Transl Res | Targeting gut-liver axis for the treatment of nonalcoholic steatohepatitis: translational and clinical evidence. | 2015 | Details |
| A19853 | 26304302 | Aliment Pharmacol Ther | Systematic review: microbial dysbiosis and nonalcoholic fatty liver disease. | 2015 | Details |
| A19861 | 26300318 | Mol Nutr Food Res | Nonalcoholic fatty liver disease: Roles of the gut and the liver and metabolic modulation by some dietary factors and especially long-chain n-3 PUFA. | 2015 | Details |
| A19890 | 26281602 | Zhongguo Zhong Yao Za Zhi | [Intervention effect and mechanism of compound Ginkgo biloba preparations on nonalcoholic fatty liver]. | 2015 | Details |
| A19932 | 26256903 | Ann Hepatol | Development of steatohepatitis in Ob/Ob mice is dependent on Toll-like receptor 4. | 2016 | Details |
| A19949 | 26246326 | J Nutr | Oral Glutamine Supplementation Protects Female Mice from Nonalcoholic Steatohepatitis. | 2015 | Details |
| A19984 | 26226097 | Clin Gastroenterol Hepatol | Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes. | 2015 | Details |
| A19996 | 26215699 | J Pharmacol Sci | JTP-103237, a monoacylglycerol acyltransferase inhibitor, prevents fatty liver and suppresses both triglyceride synthesis and de novo lipogenesis. | 2015 | Details |
| A20006 | 26212089 | J Gastroenterol Hepatol | Small intestinal bacterial overgrowth and toll-like receptor signaling in patients with non-alcoholic fatty liver disease. | 2016 | Details |